Pursuing new therapeutic options for complex disorders.
Neuropsychiatric conditions are attributed to disorders originating in the brain. The potentially severe cognitive and behavioral manifestations of these conditions can greatly affect individuals’ ability to learn, interact, work and emotionally cope with stress; often they can impair the neurological development of a child, or even cause regression of neurological progress. In the past, very little was known about these conditions and how best to treat them, but recent and ongoing research has made great headway into identifying new therapeutic approaches. We believe that by improving neural connections and modulating certain neurological pathways in the central nervous system (CNS), we may be able to impact some of these disorders.
We currently focus our work on the following rare neuropsychiatric disorders: Fragile X syndrome (FXS) and 22q11.2 deletion syndrome (22q).